矢志革新 履践致远:《2024年全球结核病报告》结核病科学研究章节解读  

Committed to innovation and striving for long-term progress:interpretation of research and innovation chapter in the Global Tuberculosis Report 2024

作　　者：舒薇[1] 刘宇红[1] Shu Wei;Liu Yuhong(Beijing Chest Hospital,Capital Medical University/Beijing Tuberculosis and Thoracic Tumor Research Institute/Clinical Center on Tuberculosis,Chinese Center for Disease Control and Prevention,Beijing 101149,China)

机构地区：[1]首都医科大学附属北京胸科医院/北京市结核病胸部肿瘤研究所/中国疾病预防控制中心结核病防治临床中心,北京101149

出　　处：《中国防痨杂志》2025年第2期137-141,共5页Chinese Journal of Antituberculosis

基　　金：北京市卫生健康委员会高层次公共卫生技术人才建设项目(学科带头人-03-11;学科带头人-01-10);北京市医院管理中心“登峰”人才培养计划(DFL20221401)。

摘　　要：加速结核病领域创新性的研究与发展是终止结核病流行的重要手段。2024年10月29日,世界卫生组织发布了《2024年全球结核病报告》,笔者就报告中结核病研究领域新诊断技术、新药与新方案及新疫苗等的研究及创新要点进行综述,并结合我国相关领域的研究进展进行分析,以期为我国结核病防治领域同行掌握结核病研究动态,进一步开展原创性研究和技术提供参考。Accelerating innovative research and development in the field of tuberculosis(TB)is one of the crucial domains to end the disease.On October 29,2024,the World Health Organization(WHO)released the Global Tuberculosis Report 2024.The author summarizes the research and innovation highlights of new diagnostic technologies,new drugs and regimens,and new vaccines as outlined in the report,and analyzes them in conjunction with research progress in related fields in China.The aim is to keep China’s TB professionals better informed about the latest global research development in TB prevention and control,and to serve as a reference for further conducting original research and technology development.

关 键 词：结核 研究 总结性报告 

分 类 号：R52[医药卫生—内科学]